Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients

RATIONALE: Radium-223-Dichloride (Ra-223) is an alpha-emitter, used to treat bone metastases. Patients with high metastatic burden and/or with increased trabecular bone uptake could present a higher incidence of hematologic toxicity. We hypothesized that these two factors are predictors of bone marr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomed Res Int
Asıl Yazarlar: Fiz, Francesco, Sahbai, Samine, Campi, Cristina, Weissinger, Matthias, Dittmann, Helmut, Marini, Cecilia, Piana, Michele, Sambuceti, Gianmario, la Fougère, Christian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757096/
https://ncbi.nlm.nih.gov/pubmed/29435457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3905216
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller